Global Validation Regulations & Standards

Electronic Archiving and Data Retention for Annex 11 and Part 11 Systems

Electronic Archiving and Data Retention for Annex 11 and Part 11 Systems The integration of electronic systems in the pharmaceutical industry necessitates rigorous adherence to regulatory expectations, particularly in relation to electronic archiving and data retention. With both the US FDA’s Part 11 regulations and the EMA’s Annex 11, understanding the specific requirements becomes paramount to ensure compliance and maintain…

Continue Reading Electronic Archiving and Data Retention for Annex 11 and Part 11 Systems

Preparing for Annex 11/Part 11–Focused Inspections: Storyboards and SME Coaching

Preparing for Annex 11/Part 11–Focused Inspections: Storyboards and SME Coaching Preparing for Annex 11/Part 11–Focused Inspections: Storyboards and SME Coaching Introduction to Inspection Readiness for Annex 11 and Part 11 In the pharmaceutical industry, compliance with regulatory standards is paramount for ensuring the quality, safety, and efficacy of products. Among these regulations, EU GMP Annex 11 and the US FDA…

Continue Reading Preparing for Annex 11/Part 11–Focused Inspections: Storyboards and SME Coaching

Hybrid Systems: Controlling Paper–Electronic Interfaces Under Annex 11 and Part 11

Hybrid Systems: Controlling Paper–Electronic Interfaces Under Annex 11 and Part 11 In today’s pharmaceutical landscape, integrating traditional paper-based processes with electronic systems has become a necessity. Hybrid systems—the combination of paper and electronic records—are prevalent in many organizations as they strive for compliance with regulatory guidelines such as the US FDA‘s requirements and the European Medicines Agency’s (EMA) Annex 11….

Continue Reading Hybrid Systems: Controlling Paper–Electronic Interfaces Under Annex 11 and Part 11

Managing Electronic Batch Records in Annex 11/Part 11–Regulated Environments

Managing Electronic Batch Records in Annex 11/Part 11–Regulated Environments Managing Electronic Batch Records in Annex 11/Part 11–Regulated Environments The pharmaceutical industry is undergoing a significant transformation with the increasing reliance on electronic batch records (EBR) to streamline operations and enhance compliance with regulatory requirements. The validation and management of EBR in accordance with 21 CFR Part 11 and EU GMP…

Continue Reading Managing Electronic Batch Records in Annex 11/Part 11–Regulated Environments

21 CFR Part 11 and Annex 11 for LIMS, QMS and MES Platforms

21 CFR Part 11 and Annex 11 for LIMS, QMS, and MES Platforms Introduction to Regulatory Validation Expectations In the highly regulated pharmaceutical industry, compliance with validation requirements for computerized systems, particularly for Laboratory Information Management Systems (LIMS), Quality Management Systems (QMS), and Manufacturing Execution Systems (MES), is crucial. This article provides an in-depth regulatory explainer manual addressing the expectations…

Continue Reading 21 CFR Part 11 and Annex 11 for LIMS, QMS and MES Platforms

Change Control for Annex 11/Part 11 Systems: Impact Assessment and Regression Testing

Change Control for Annex 11/Part 11 Systems: Impact Assessment and Regression Testing Change control is a core component of pharmaceutical validation, particularly when it concerns computerized systems governed by Annex 11 of the EU GMP Guidelines and 21 CFR Part 11 from the FDA. This regulatory explainer manual provides a comprehensive overview of change control requirements for these systems, emphasizing…

Continue Reading Change Control for Annex 11/Part 11 Systems: Impact Assessment and Regression Testing

ISO 14644 Cleanroom Classification Explained for EU GMP and FDA-Regulated Sites

ISO 14644 Cleanroom Classification Explained for EU GMP and FDA-Regulated Sites The classification of cleanrooms is a critical aspect of maintaining compliance with pharmaceutical manufacturing regulations in the US, UK, and EU. Understanding the ISO 14644 cleanroom classification standards is essential for pharmaceutical companies to align with cGMP requirements, especially in light of EU GMP Annex 1, which governs the…

Continue Reading ISO 14644 Cleanroom Classification Explained for EU GMP and FDA-Regulated Sites

Routine Environmental Monitoring Under ISO 14644 and Annex 1

Routine Environmental Monitoring Under ISO 146644 and Annex 1 In the pharmaceutical industry, ensuring the manufacturing environment is suitable for producing safe and effective products is paramount. Routine environmental monitoring (EM) plays a critical role in this by systematically assessing the cleanliness of controlled environments. ISO 14644 standards, along with Annex 1 of the EU GMP guidelines, provide essential frameworks…

Continue Reading Routine Environmental Monitoring Under ISO 14644 and Annex 1

ISO 14644-1 vs Annex 1: Aligning Cleanroom Classes, Grades and Sampling Strategies

ISO 14644-1 vs Annex 1: Aligning Cleanroom Classes, Grades and Sampling Strategies ISO 14644-1 vs Annex 1: Aligning Cleanroom Classes, Grades and Sampling Strategies Introduction to Cleanroom Standards In the pharmaceutical industry, maintaining the integrity of cleanrooms is imperative for ensuring product quality and compliance with regulatory requirements. The two prominent standards in cleanroom classification are ISO 14644-1 and the…

Continue Reading ISO 14644-1 vs Annex 1: Aligning Cleanroom Classes, Grades and Sampling Strategies

HEPA Filter Integrity Testing and Leak Location Under ISO 14644

HEPA Filter Integrity Testing and Leak Location Under ISO 14644 Introduction to HEPA Filter Integrity Testing HEPA (High Efficiency Particulate Air) filters are critical components in controlled environments such as cleanrooms, operating theaters, and pharmaceutical manufacturing facilities. They ensure that the air quality adheres to stringent regulatory standards set forth by the US FDA, EMA, and other authorities. Performing HEPA…

Continue Reading HEPA Filter Integrity Testing and Leak Location Under ISO 14644